Magro, F., Lopes, S., Silva, M., Coelho, R., Portela, F., Branquinho, D., Correia, L., Fernandes, S., Cravo, M., Caldeira, P., Sousa, H. T., Patita, M., Lago, P., Ramos, J., Afonso, J., Redondo, I., Machado, P., Cornillie, F., Lopes, J., Carneiro, F., & , (2019). low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study. Journal of Crohn's and colitis, 13, 1387–1393. http://access.bl.uk/ark:/81055/vdc_100094625064.0x00000e